CASE THURMAN K
Known title: VP & CFOCIK: 0001270350
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
CRUS Announces Acquisition of INVENTVM Semiconductor. Cirrus Logic announced it will acquire INVENTVM Semiconductor, a move that could broaden its product lineup. The company remains debt‑free and is trading at a discount, with a 56% run‑up still in place. Analysts see it as a value play, with a 52‑week range of $106.26 to $180.42 and a target of $165.00.
Transaction History
| HELE | ▲ Buy | Grant | 860 | $0 | 9/1/2026 | View on chart |
| HELE | ▲ Buy | Grant | 919 | $0 | 6/1/2026 | View on chart |
| HELE | ▲ Buy | Grant | 1,429 | $0 | 3/2/2026 | View on chart |
| HELE | ▲ Buy | Grant | 1,253 | $0 | 12/1/2025 | View on chart |
| HELE | ▲ Buy | Grant | 992 | $0 | 9/2/2025 | View on chart |
| HELE | ▲ Buy | Grant | 933 | $0 | 6/2/2025 | View on chart |
| HELE | ▲ Buy | Grant | 457 | $0 | 3/3/2025 | View on chart |
| HELE | ▲ Buy | Grant | 333 | $0 | 12/2/2024 | View on chart |
| HELE | ▲ Buy | Grant | 458 | $0 | 9/3/2024 | View on chart |
| HELE | ▲ Buy | Grant | 231 | $0 | 6/3/2024 | View on chart |
| HELE | ▲ Buy | Grant | 197 | $0 | 3/1/2024 | View on chart |
| HELE | ▲ Buy | Grant | 223 | $0 | 12/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 201 | $0 | 9/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 261 | $0 | 6/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 222 | $0 | 3/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 242 | $0 | 12/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 196 | $0 | 9/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 127 | $0 | 6/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 121 | $0 | 3/1/2022 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 1,500 | $31K | 1/12/2022 | View on chart |
| CRUS | ▼ Sell | Open Market | 1,500 | $143K | 1/12/2022 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 1,543 | $31K | 12/13/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 1,543 | $147K | 12/13/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 2,000 | $190K | 12/13/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 2,000 | $63K | 12/9/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 2,000 | $180K | 12/9/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 2,000 | $47K | 12/9/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 2,000 | $180K | 12/9/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 200 | $18K | 12/9/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 1,000 | $85K | 12/7/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 1,000 | $31K | 12/7/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 5,000 | $195K | 12/7/2021 | View on chart |
| CRUS | ▼ Sell | Open Market | 5,000 | $425K | 12/7/2021 | View on chart |
| HELE | ▲ Buy | Grant | 97 | $0 | 12/1/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 992 | $0 | 11/7/2021 | View on chart |
| CRUS | ▼ Sell | Tax Withholding | 391 | $31K | 11/7/2021 | View on chart |
| CRUS | ▲ Buy | Option Exercise | 4,300 | $0 | 11/7/2021 | View on chart |
| CRUS | ▼ Sell | Tax Withholding | 1,203 | $95K | 11/7/2021 | View on chart |
| HELE | ▲ Buy | Grant | 97 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
HELE Q2 Earnings Beat Estimates, Guidance Raised
Helen of Troy reported second‑quarter results that topped analysts’ expectations, driven by higher margins. The company also lifted its outlook for the coming period. Analysts note the stock may benefit from lower U.S.–China tariffs on consumer electronics, and UBS raised its price target while keeping a neutral stance. These points add to recent commentary describing the stock as attractively priced.
HELE Q2 Earnings Beat Estimates, Guidance Raised. Helen of Troy reported second‑quarter results that topped analysts’ expectations, driven by higher margins. The company also lifted its outlook for the coming period. Analysts note the stock may benefit from lower U.S.–China tariffs on consumer electronics, and UBS raised its price target while keeping a neutral stance. These points add to recent commentary describing the stock as attractively priced.